DigiPath, Inc. together with its subsidiaries, provides cannabis related testing services in the United States. The company offers cannabis lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides a balanced and unbiased approach to cannabis news, interviews, and education with a news/talk radio show, app, national marijuana news Website, and social media presence focusing on the political, economic, medicinal, scientific, and cultural dimensions of medicinal and recreational marijuana industry. DigiPath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryCannabis
SectorMedical
Phone702-527-2060
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.55 million
Profitability
Miscellaneous
Employees18
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable
Digipath (OTCMKTS:DIGP) Frequently Asked Questions
What is Digipath's stock symbol?
Digipath trades on the OTCMKTS under the ticker symbol "DIGP."
How were Digipath's earnings last quarter?
Digipath Inc (OTCMKTS:DIGP) issued its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.65 million for the quarter. Digipath had a negative return on equity of 251.52% and a negative net margin of 57.50%. View Digipath's Earnings History.
When is Digipath's next earnings date?
Has Digipath been receiving favorable news coverage?
Headlines about DIGP stock have trended neutral this week, InfoTrie reports. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Digipath earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Digipath.
Who are some of Digipath's key competitors?
Some companies that are related to Digipath include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), OrganiGram (OGI), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), GrowGeneration (GRWG), KushCo (KSHB), 22nd Century Group (XXII), mCig (MCIG), General Cannabis (CANN), Terra Tech (TRTC), Grow Capital (GRWC) and Nemus Bioscience (NMUS).
What other stocks do shareholders of Digipath own?
Who are Digipath's key executives?
Digipath's management team includes the folowing people:
- Mr. Todd Denkin, Founder, Chairman, CEO & Pres (Age 55)
- Mr. Todd A. Peterson, CFO, Principal Accounting Officer, Treasurer & Sec. (Age 49)
- Dr. Cindy Sue Orser, Chief Science Officer & Director (Age 63)
- Dr. Drazen M. Jukic M.D., Ph.D., Exec. Officer
- Mr. Bo Deitl, Consultant
How do I buy shares of Digipath?
Shares of DIGP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Digipath's stock price today?
One share of DIGP stock can currently be purchased for approximately $0.07.
How big of a company is Digipath?
What is Digipath's official website?
How can I contact Digipath?
Digipath's mailing address is 6450 CAMERON STREET SUITE 113, LAS VEGAS NV, 89118. The company can be reached via phone at 702-527-2060.
MarketBeat Community Rating for Digipath (OTCMKTS DIGP)
MarketBeat's community ratings are surveys of what our community members think about Digipath and other stocks. Vote "Outperform" if you believe DIGP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DIGP will underperform the S&P 500 over the long term. You may vote once every thirty days.
